Format

Send to

Choose Destination
J Clin Invest. 2000 Jan;105(1):3-7.

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Author information

1
Division of Hematology, Oregon Health Sciences University, Portland, Oregon 97201, USA.
PMID:
10619854
PMCID:
PMC382593
DOI:
10.1172/JCI9083
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center